// App-Quantinova.ai

: Real World Use of Thrombopoietin-Receptor Agonists in the Management of Immune Thrombocytopenia in the United Kingdom: Results from the TRAIT Study

Researchers

Presenter

  • Nichola Cooper

Principal Investigators

  • Andrew Provan

  • Marie Scully

  • Henri Grech

  • Catherine Bagot

  • Quentin A Hill

  • Tim Nokes

  • Nicholas Ramscar

  • Luke Saunders

Medical Centers

  • Imperial College, London, United Kingdom

  • Barts and the London School of Medicine, London, United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Royal Berkshire NHS Foundation Trust, Reading, United Kingdom

  • Glasgow Royal Infirmary, Glasgow, UK

  • Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds UK, Leeds, UK

  • Derriford Hosipital, Plymouth Hospital NHS Trust, Plymouth, United Kingdom

  • Novartis Oncology, Camberley, Surrey

  • pH Associates Ltd, Marlow, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

  • Transplant renal artery stenosis

Biomarkers

  • T cell receptor alpha locus

Drug/Treatment

  • Eltrombopag

  • Romiplostim

  • Mofezolac

Outcome

  • N/A

Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved